Uyen Minh Le

Uyen Minh Le

Auto-generated profile, based on publicly available information

Uyen Minh Le

College of Pharmacy, California Northstate University, 9700 West Taron Drive, Elk Grove, California 95757, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TTTuan T Tran
Tuan T Tran
ULUyen Le
Uyen Le
YSYihui Shi
Yihui Shi
Early detection of breast cancer plays a critical role in successful treatment that saves thousands of lives of patients every year. Despite massive clinical data have been collected and stored by healthcare organizations, only a small portion of the data has been used to support decision-making for treatments. In this study, we proposed an engineered up-sampling method (ENUS) for handling imbalanced data to improve predictive performance of machine learning models. Our experiment results showed that when the ratio of the minority to the majority class is less than 20%, training models with ENUS improved the balanced accuracy 3.74%, sensitivity 8.36% and F1 score 3.83%. Our study also identified that XGBoost Tree (XGBTree) using ENUS achieved the best performance with an average balanced accuracy of 97.47% (min = 93%, max = 100%), sensitivity of 97.88% (min = 89% and max = 100%), and F1 score of 96.20% (min = 89.5%, max = 100%) in the validation dataset. Furthermore, our ensemble algorithm identified Cell_Shape and Nuclei as the most important attributes in predicting breast cancer. The finding re-affirms the previous knowledge of the relationship between Cell_Shape, Nuclei, and the grades of breast cancer using a data-driven approach. Finally, our experiment showed that Random Forest and Neural Network models had the least training time. Our study provided a comprehensive comparison of a wide range of machine learning methods in predicting breast cancer risk. It can be used as a tool for healthcare practitioners to effectively detect and treat breast cancer.

28 October 2022 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
HWHongbin Wang
Hongbin Wang
TTTuan T. Tran
Tuan T. Tran
KDKatherine T. Duong
Katherine T. Duong
TNTrieu Nguyen
Trieu Nguyen
ULUyen M. Le
Uyen M. Le

1 March 2020 in Currents in Pharmacy Teaching and Learning
Verified
Journal Article
Closed access
MRMike Rudolph
Mike Rudolph
JGJustine S. Gortney
Justine S. Gortney
ABAngela Brownfield
Angela Brownfield
DCDavid Caldwell
David Caldwell
ACAshley Castleberry
Ashley Castleberry
KDKimberly K. Daugherty
Kimberly K. Daugherty